Capricor Therapeutics Faces Securities Lawsuit

Capricor Therapeutics Faces Securities Lawsuit

Capricor Therapeutics, a biopharmaceutical company focused on developing innovative therapies for severe medical conditions, is currently facing a securities lawsuit stemming from allegations of misleading investors. This legal challenge highlights…
Cboe Raises Quarterly Dividend 19% to $0.86

Cboe Raises Quarterly Dividend 19% to $0.86

Cboe Global Markets, a leading exchange operator, has increased its quarterly dividend by an impressive 19%, raising it to $0.86 per share. This announcement reflects the company's strong financial performance…